[HTML][HTML] 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
WEE Eberhardt, D De Ruysscher, W Weder… - Annals of …, 2015 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer
L Schrevens, N Lorent, C Dooms… - The oncologist, 2004 - academic.oup.com
Positron emission tomography (PET) is now an important cancer imaging tool, both for
diagnosis and staging, as well as offering prognostic information based on response. This …
diagnosis and staging, as well as offering prognostic information based on response. This …
Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review
J Vansteenkiste, BM Fischer, C Dooms… - The lancet …, 2004 - thelancet.com
Positron-emission tomography (PET) with 18-fluorodeoxyglucose has a role in the diagnosis
and staging of lung cancer, but is also appealing for assessment of prognosis and treatment …
and staging of lung cancer, but is also appealing for assessment of prognosis and treatment …
[HTML][HTML] Perioperative pembrolizumab for early-stage non–small-cell lung cancer
H Wakelee, M Liberman, T Kato, M Tsuboi… - … England Journal of …, 2023 - Mass Medical Soc
Background Among patients with resectable early-stage non–small-cell lung cancer
(NSCLC), a perioperative approach that includes both neoadjuvant and adjuvant immune …
(NSCLC), a perioperative approach that includes both neoadjuvant and adjuvant immune …
[HTML][HTML] 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard… - Annals of …, 2014 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer
P De Leyn, C Dooms, J Kuzdzal… - European journal of …, 2014 - academic.oup.com
Accurate preoperative staging and restaging of mediastinal lymph nodes in patients with
potentially resectable non-small-cell lung cancer (NSCLC) is of paramount importance. In …
potentially resectable non-small-cell lung cancer (NSCLC) is of paramount importance. In …
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial
JT Annema, JP Van Meerbeeck, RC Rintoul, C Dooms… - Jama, 2010 - jamanetwork.com
Context Mediastinal nodal staging is recommended for patients with resectable non–small
cell lung cancer (NSCLC). Surgical staging has limitations, which results in the performance …
cell lung cancer (NSCLC). Surgical staging has limitations, which results in the performance …
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
AJ de Langen, ML Johnson, J Mazieres… - The Lancet, 2023 - thelancet.com
Background Sotorasib is a specific, irreversible inhibitor of the GTPase protein, KRAS G12C.
We compared the efficacy and safety of sotorasib with a standard-of-care treatment in …
We compared the efficacy and safety of sotorasib with a standard-of-care treatment in …
[HTML][HTML] Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages
How the innate and adaptive host immune system miscommunicate to worsen COVID-19
immunopathology has not been fully elucidated. Here, we perform single-cell deep-immune …
immunopathology has not been fully elucidated. Here, we perform single-cell deep-immune …
[HTML][HTML] Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
KM Kerr, L Bubendorf, MJ Edelman, A Marchetti… - Annals of …, 2014 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The Second …
consensus conferences to focus on specific issues in each type of tumour. The Second …